Quarterly ResultAug 13, 2026, 04:46 PM
Health In Tech Q2 Revenue $8.1M, Net Loss $2.5M; Reaffirms FY26 Guidance
AI Summary
Health In Tech, Inc. reported Q2 2026 revenue of $8.1 million, a decrease from $9.3 million in Q2 2025, and a net loss of $2.5 million, compared to net income of $0.6 million in the prior year. Despite the decline in GAAP revenue and net income, the company saw its distribution partners grow by 19.9% year-over-year and reported $32.3 million in contracted revenue for the first half of 2026. Health In Tech reaffirmed its full-year 2026 revenue guidance of $45 million to $50 million and announced progress on strategic initiatives, including securing its first employer group for the Three-Year Rate Stabilization Program and the upcoming launch of its HitRix platform.
Key Highlights
- Q2 2026 revenue was $8.1 million, down from $9.3 million in Q2 2025.
- Net loss for Q2 2026 was $2.5 million, or $(0.04) per diluted share.
- Distribution Partners grew 19.9% year-over-year to 933 as of June 30, 2026.
- Contracted Revenue totaled $32.3 million for first-half 2026.
- Pipeline Revenue was $66.3 million as of July 31, 2026.
- Reaffirmed full-year 2026 revenue guidance of $45 million to $50 million.
- Secured first employer group for Three-Year Rate Stabilization Program.
- Plans to launch new HitRix marketplace platform in second half of 2026.
Price Impact
More from HIT